- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03865693
Effects of Pain Scrambler Therapy for the Alterations of Cerebral Blood
18. juni 2019 opdateret af: Hangang Sacred Heart Hospital
Effects of Pain Scrambler Therapy for the Alterations of Cerebral Blood Volume in Pain Network of Neuropathic Pain on Burn Patients
Prevalence of chronic pain has been shown to be high after thermal injury.
Post-burn neuropathic pain causes chronic disabilities that is often difficult to treat effectively.
Pain Scrambler therapy is a patient-specific electrocutaneous nerve stimulation device.
To study changes in the pain network associated with neuropathic pain, magnetic resonance imaging(MRI) was used to evaluate cerebral blood volume(CBV) in patients who had been injuried by burn.
Participants (N=40, experimental 20 and control group 20) comprised patients with neuropathic pain after thermal injury.
The subjects complained of severe neuropathic pain that was rated at least 5 on the visual analogue scale (VAS), despite treatments with gabapentin medication and other physical modalities.
Each Scrambler therapy with the MC5-A Calmare® therapy device (Competitive Technologies, Inc. Fairfield, USA ) was performed for 40 min daily (Monday through Friday) for 10 consecutive days.
The stimulus was increased to the maximum intensity bearable by the individual patient without causing any additional pain or discomfort.
The intensity of neuropathic pain was measured using the visual analogue scale(VAS).
Depressive mood was assessed using the Beck Depression Scale.
Voxel-wise comparisons of relative CBV maps were made between before scrambler therapy and after 10 scrambler therapy sessions over the entire brain volume.
The relationship between individual participant CBV(measured in voxels), BDS and VAS score was also examined.
We observed decreased in the cerebral pain network of patients with burn injury.
Scrambler therapy is a non-invasive, non-medicinal modality that significantly reduced burn-associated neuropathic pain.
Scrambler therapy should be considered as a treatment option for burn survivors with severe neuropathic pain.
Studieoversigt
Detaljeret beskrivelse
The groups (scrambler therapy and sham therapy) were randomly assigned.
All subjects were recruited in scrambler thrapy and sham stimulation.
Main study outcomes included group differences in CBV changed and the the relationship between CBV changes and neuropathic pain intensity.
These analyses were performed using the same framework of the general linear model, which was repeatedly applied to each voxel with the same coordinates.
Undersøgelsestype
Interventionel
Tilmelding (Forventet)
40
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Yeong-deungpo-Dong
-
Seoul, Yeong-deungpo-Dong, Korea, Republikken, 150-719
- Rekruttering
- Hangang Sacred Heart Hospital
-
Ledende efterforsker:
- So Young Joo, M.D.
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 65 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Burn patients
- severe neuropatic pain rated at least 5 on the 10-point numerical rating scale (NRS)
Exclusion Criteria:
- cardiac arrest history
- history of neurologi disease or brain surgery
- unstable heart disease or presence of a cardiac pacemaker
- pain resulting from other causes like as neuromuscular diseases
- psychiatric disorder
- diabetes mellitus
- abnormal renal function
- contraindication for MRI, or pregnancy.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: scarmbler treatment group
Each Scrambler therapy with the MC5-A Calmare® therapy device (Competitive Technologies, Inc. Fairfield, USA ) was performed for 40 min daily (Monday through Friday) for 10 consecutive days.
The experimental participants were received scarmbler therapy 10 times for 2 weeks.
The stimulus was increased to the maximum intensity bearable by the individual patient without causing any additional pain or discomfort.
|
Scrambler therapy is a patient-specific electrocutaneous nerve stimulation device.
|
|
Sham-komparator: sham treatment group
conservative management without scarmbler therapy
|
Scrambler therapy is a patient-specific electrocutaneous nerve stimulation device.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
neuropathic pain score
Tidsramme: after 4 weeks scrambler therapy
|
visual analog scale, Zero ("0") represented no pain and 10 represented unbearable symptoms
|
after 4 weeks scrambler therapy
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Cerebral blood volume
Tidsramme: after 4 weeks scrambler therapy
|
Cerebral blood volume(CBV) is a hemodynamic variable that is highly correlated with oxygen metabolism, representing the fraction of cerebral tissue volume occupied by blood at a given time point.
|
after 4 weeks scrambler therapy
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Cheong Hoon Seo, M.D., Hangang Sacred Heart Hospital
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Generelle publikationer
- Joo SY, Cho YS, Cho SR, Kym D, Seo CH. Effects of pain Scrambler therapy for management of burn scar pruritus: A pilot study. Burns. 2017 May;43(3):514-519. doi: 10.1016/j.burns.2016.09.028. Epub 2016 Oct 15.
- Majithia N, Smith TJ, Coyne PJ, Abdi S, Pachman DR, Lachance D, Shelerud R, Cheville A, Basford JR, Farley D, O'Neill C, Ruddy KJ, Sparadeo F, Beutler A, Loprinzi CL. Scrambler Therapy for the management of chronic pain. Support Care Cancer. 2016 Jun;24(6):2807-14. doi: 10.1007/s00520-016-3177-3. Epub 2016 Apr 4.
- Lee SY, Park CH, Cho YS, Kim L, Yoo JW, Joo SY, Seo CH. Scrambler Therapy for Chronic Pain after Burns and Its Effect on the Cerebral Pain Network: A Prospective, Double-Blinded, Randomized Controlled Trial. J Clin Med. 2022 Jul 22;11(15):4255. doi: 10.3390/jcm11154255.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Forventet)
1. juli 2019
Primær færdiggørelse (Forventet)
31. august 2020
Studieafslutning (Forventet)
30. november 2020
Datoer for studieregistrering
Først indsendt
5. marts 2019
Først indsendt, der opfyldte QC-kriterier
5. marts 2019
Først opslået (Faktiske)
7. marts 2019
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
20. juni 2019
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
18. juni 2019
Sidst verificeret
1. juni 2019
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- HangangSHH-3
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Uafklaret
IPD-planbeskrivelse
after review
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .